(lp0
S'Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for ... GlobeNewswire  - Feb 23, 2017 PLAINSBORO, N.J., Feb. 23, 2017  -- Integra LifeSciences Holdings Corporation  , a global leader in medical technology, announced today that its tender offer by its wholly-owned subsidiary, Integra Derma, Inc.Integra  Posts In-Line Q4 Earnings, Issues 2017 View - Nasdaq'
p1
aS'Derma Sciences to Be Acquired by Integra LifeSciences for $7.00 Per Share of ... Business Wire  - Jan 11, 2017 PRINCETON, N.J.----Derma Sciences, Inc. , a tissue regeneration company focused on advanced wound and burn care, today announced that it has signed a definitive agreement whereby Derma Sciences will be acquired&nbsp;...Integra to Acquire Derma Sciences for $204M - Genetic Engineering & Biotechnology News '
p2
aS'Integra LifeSciences Commences Previously Announced Cash Tender Offer to ... GlobeNewswire  - Jan 25, 2017 PLAINSBORO, N.J., Jan. 25, 2017  -- Integra LifeSciences Holdings Corporation  , a global leader in medical technology, announced today that its wholly-owned subsidiary, Integra Derma, Inc. ,&nbsp;...BRIEF-Integra Lifesciences starts tender offer to buy Derma Sciences - Reuters'
p3
aS"Derma Sciences Hit With Suits Over $204M Integra Buy Law360  - Feb 1, 2017 Law360, New York  -- Integra LifeSciences Holdings Corp.'s proposal to buy Derma Sciences Inc. is unfair to shareholders because it undervalues the company and unfairly rewards Derma Sciences executives, according to&nbsp;..."
p4
aS'Derma Sciences Announces Leadership and CEO Transition Business Wire  - Dec 21, 2015 PRINCETON, N.J.----Derma Sciences, Inc. , a tissue regeneration company focused on advanced wound and burn care, announces that Stephen T. Wills, the Lead Director and a member of the Derma Sciences Board of&nbsp;...'
p5
aS'Derma Sciences Announces Results of Futility Analyses for Phase 3 Clinical ... Business Wire  - Nov 12, 2015 PRINCETON, N.J.----Derma Sciences, Inc. , a tissue regeneration company focused on advanced wound and burn care, announces the termination of its Phase 3 clinical trials with aclerastide  for diabetic foot ulcer&nbsp;...'
p6
aS'Derma Sciences exploring sale after scrapping drug program Reuters - Nov 12, 2015 Derma Sciences Inc DSCI.O said on Thursday it would evaluate all options, including a sale of the company, after stopping development of its only drug.'
p7
aS"Derma Sciences closes $80m deal for BioD Mass Device - Aug 12, 2016 The buyout increased Derma Sciences' sales footprint by more than 300%, adding BioD's 235 independent sales reps and 7 direct reps to it own 63-member team of inside and independent reps."
p8
aS'Derma Sciences Hit With Another Suit Over Integra Buy Law360  - Feb 3, 2017 Law360, New York  -- Another Derma Sciences Inc. shareholder on Friday added his name to the list of proposed class actions filed against the company over Integra LifeSciences Holdings Corp.'
p9
aS'Deal Could Cost Derma Sciences Inc.  $78 Million Scibility Media - Jul 29, 2016 Derma Sciences Inc  is on track to swallow privately-held BioD in a deal that will see it part with $21.3 million upfront and about $77.8 million in total.$77.8M deal: Princeton tissue regeneration firm buys Tennessee company - Philadelphia Business Journal'
p10
a.